2023
DOI: 10.3390/pharmaceutics16010034
|View full text |Cite
|
Sign up to set email alerts
|

Lipid-Based Nanotechnology: Liposome

Yanhao Jiang,
Wenpan Li,
Zhiren Wang
et al.

Abstract: Over the past several decades, liposomes have been extensively developed and used for various clinical applications such as in pharmaceutical, cosmetic, and dietetic fields, due to its versatility, biocompatibility, and biodegradability, as well as the ability to enhance the therapeutic index of free drugs. However, some challenges remain unsolved, including liposome premature leakage, manufacturing irreproducibility, and limited translation success. This article reviews various aspects of liposomes, including… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 229 publications
(258 reference statements)
0
3
0
Order By: Relevance
“…This "stealth" effect is produced by inducing protein binding and regulation as well as reducing degradation using metabolic enzymes. This is due to the fact that certain polymers block the entry or recognition of blood proteins, protein hydrolases, and antibodies during blood circulation [32]. Such an assembly structure will enable it to have a higher drug loading capacity when encapsulating the drug, and a certain thickness of the shell will enable it to pass through the gastrointestinal tract without leaking the drug and gradually release the drug when it reaches the target site in the intestine, so as to achieve the effect of controlled release.…”
Section: Multilayered Types Of Controlled Release Nano-formulationsmentioning
confidence: 99%
“…This "stealth" effect is produced by inducing protein binding and regulation as well as reducing degradation using metabolic enzymes. This is due to the fact that certain polymers block the entry or recognition of blood proteins, protein hydrolases, and antibodies during blood circulation [32]. Such an assembly structure will enable it to have a higher drug loading capacity when encapsulating the drug, and a certain thickness of the shell will enable it to pass through the gastrointestinal tract without leaking the drug and gradually release the drug when it reaches the target site in the intestine, so as to achieve the effect of controlled release.…”
Section: Multilayered Types Of Controlled Release Nano-formulationsmentioning
confidence: 99%
“…lipids can effectively be used to encapsulate both hydrophilic within the inner aqueous compartment or hydrophobic in the lipid acyl chain region. Indeed, lipids serve as a protective barrier for the enclosed molecular cargo, ensuring its stability 13,14 .…”
Section: Introductionmentioning
confidence: 99%
“…lipids can effectively be used to encapsulate both hydrophilic within the inner aqueous compartment or hydrophobic in the lipid acyl chain region. Indeed, lipids serve as a protective barrier for the enclosed molecular cargo, ensuring its stability 13,14 . Indeed, lipid molecules can effortlessly diffuse through the membrane, where van der Waals interactions among hydrocarbon chains propel the internalization of the lipid membrane 15 .…”
Section: Introductionmentioning
confidence: 99%